Visible-light photoredox catalysis has been esteemed as one sustainable and attractive synthetic tool. In the past four years, a new yet challenging trend, visible-light-driven redox-neutral radical C-C cross-coupling involving putative radical intermediates, has been booming rapidly. Its advent brings a powerful platform to achieve non-classical C-C connections, and should lead to fundamental changes in retrosynthetic analysis. In this tutorial review, we highlight the recent achievements of visible-light-mediated redox-neutral radical C(sp)-C(sp), C(sp)-C(sp), and C(sp)-C(sp) bond formation, opening a new window for C-C cross-coupling through the photoredox electron shuttling cycle between two coupling partners. While radical-radical coupling steered by the persistent radical effect was proposed as a rational explanation for the redox-neutral photoredox events, alternative kinetically driven chain propagation and radical addition pathways cannot be ruled out. This tutorial review aims to highlight the recent achievements of photoredox-neutral radical C-C coupling in synthetic chemistry.
The gold-catalyzed C-H annulation of anthranil derivatives with alkynes offers a facile, flexible, and atom-economical one-step route to unprotected 7-acylindoles. An intermediate α-imino gold carbene, generated by an intermolecular reaction, promotes ortho-aryl C-H functionalization to afford the target products. The transformation proceeds with a broad range of substrates under mild conditions. Moreover, the obtained functionalized indole products represent a versatile platform for the construction of diverse indolyl frameworks.
Within
the wide family of gold-catalyzed reactions, gold photocatalysis
intrinsically features unique elementary steps. When gold catalysis
meets photocatalysis, a valence change of the gold center can easily
be achieved via electron transfer and radical addition, avoiding the
use of stoichiometric sacrificial external oxidants. The excellent
compatibility of radicals with gold catalysts opens the door to a
series of important organic transformations, including redox-neutral
C–C and C–X coupling, C–H activation, and formal
radical–radical cross-coupling. The photocatalysis with gold
complexes nicely complements the existing photoredox catalysis strategies
and also opens a new avenue for gold chemistry. This review covers
the achieved transformations for both mononuclear gold(I) catalysts
(with and without a photosensitizer) and dinuclear gold(I) photocatalysts.
Various fascinating methodologies, their value for organic chemists,
and the current mechanistic understanding are discussed. The most
recent examples also demonstrate the feasibility of both, mononuclear
and dinuclear gold(I) complexes to participate in excited state energy
transfer (EnT), rather than electron transfer. The rare applications
of gold(III) photocatalysts, both homogeneous and heterogeneous, are
also summarized.
An unprecedented and challenging radical-radical cross-coupling of α-aminoalkyl radicals with monofluoroalkenyl radicals derived from gem-difluoroalkenes was achieved. This first example of tandem C(sp(3) )-H and C(sp(2) )-F bond functionalization through visible-light photoredox catalysis offers a facile and flexible access to privileged tetrasubstituted monofluoroalkenes under very mild reaction conditions. The striking features of this redox-neutral method in terms of scope, functional-group tolerance, and regioselectivity are illustrated by the late-stage fluoroalkenylation of complex molecular architectures such as bioactive (+)-diltiazem, rosiglitazone, dihydroartemisinin, oleanic acid, and androsterone derivatives, which represent important new α-amino C-H monofluoroalkenylations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.